Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferoxamine in aneurysmal subarachnoid hemorrhage
NL-OMON45310Withdrawn
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in subarachnoid hemorrhage (SAH) comparing Deferoxamine with Placebo (2 arms). Primary endpoints: Occurrence of delayed cerebral ischemia and Drug-related adverse events. Planned start Jan 2018; status: withdrawn.
02
Drugs
deferoxamine
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NL-OMON45310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45310.